These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 27357278)

  • 1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.
    Li G; De Clercq E
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):679-731. PubMed ID: 27357278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Entry Inhibitors: A Review of Experimental and Computational Studies.
    Mostashari Rad T; Saghaie L; Fassihi A
    Chem Biodivers; 2018 Oct; 15(10):e1800159. PubMed ID: 30027572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.
    Teixeira C; Gomes JR; Gomes P; Maurel F; Barbault F
    Eur J Med Chem; 2011 Apr; 46(4):979-92. PubMed ID: 21345545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents.
    Mathys L; Balzarini J
    Retrovirology; 2014 Dec; 11():107. PubMed ID: 25499264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.
    Zhou X; Liu Z; Zhang J; Adelsberger JW; Yang J; Burton GF
    BMC Microbiol; 2016 Jul; 16(1):172. PubMed ID: 27473095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.
    Frey G; Rits-Volloch S; Zhang XQ; Schooley RT; Chen B; Harrison SC
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13938-43. PubMed ID: 16963566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
    Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
    Rivero-Buceta E; Doyagüez EG; Colomer I; Quesada E; Mathys L; Noppen S; Liekens S; Camarasa MJ; Pérez-Pérez MJ; Balzarini J; San-Félix A
    Eur J Med Chem; 2015 Dec; 106():34-43. PubMed ID: 26513643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).
    Li W; Lu L; Li W; Jiang S
    Expert Opin Ther Pat; 2017 Jun; 27(6):707-719. PubMed ID: 28076686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Replication inhibitors targeting early events in the HIV-1 life cycle].
    Ichiyama K; Yamamoto N
    Nihon Rinsho; 2002 Apr; 60(4):784-9. PubMed ID: 11968789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ; Pang W; Zheng YT; Dupré DJ
    Eur J Immunol; 2012 Feb; 42(2):299-310. PubMed ID: 22028271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV entry inhibitors: mechanisms of action and resistance pathways.
    Briz V; Poveda E; Soriano V
    J Antimicrob Chemother; 2006 Apr; 57(4):619-27. PubMed ID: 16464888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Gag, Envelope, and Extracellular Determinants Cooperate To Regulate the Stability and Turnover of Virological Synapses.
    Gardiner JC; Mauer EJ; Sherer NM
    J Virol; 2016 Jul; 90(14):6583-6597. PubMed ID: 27170746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
    Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
    PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1.
    Guzzo C; Fox JC; Miao H; Volkman BF; Lusso P
    J Virol; 2015 Sep; 89(17):9061-7. PubMed ID: 26085164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function.
    Bellamy-McIntyre AK; Bär S; Ludlow L; Drummer HE; Poumbourios P
    Biochem Biophys Res Commun; 2010 Apr; 394(4):904-8. PubMed ID: 20230797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
    Pandey D; Podder A; Pandit M; Latha N
    J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.